Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Programmed cell death and radioresistance

R E Meyn1, L C Stephens, L Milas

  • 1Department of Experimental Radiotherapy, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Cancer Metastasis Reviews
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetics of self incompatibility in diploid Ageratum houstonianum mill.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Transformation of Solanum brevidens using Agrobacterium tumefaciens.

Plant cell reports·2013
Same author

Agrobacterium T-DNA mutation causes the loss of GUS expression in transgenic tobacco.

Plant cell reports·2013
Same author

Systematic review of oxytocin dosing at caesarean section.

Anaesthesia and intensive care·2012
Same author

Phentermine and anaesthesia.

Anaesthesia and intensive care·2005
Same author

Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings.

International journal of radiation biology·2003
Same journal

HER2 assessment in urothelial carcinoma: standardization challenges and the path forward.

Cancer metastasis reviews·2026
Same journal

Resolving translational challenges in cancer biology through yeast experimental evolution.

Cancer metastasis reviews·2026
Same journal

Spheroids and organoids to study long noncoding RNAs in cancer: how they could replace animal models.

Cancer metastasis reviews·2026
Same journal

Strategies and successes of smoking cessation methods in head and neck cancer patients: a systematic review.

Cancer metastasis reviews·2026
Same journal

The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities.

Cancer metastasis reviews·2026
Same journal

Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progress.

Cancer metastasis reviews·2026
See all related articles

Tumor cell apoptosis, or programmed cell death, is crucial for radiation therapy effectiveness. Pretreatment apoptosis levels in tumors predict how well they respond to radiation, highlighting its role in cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Radiation Biology

Background:

  • Apoptosis (programmed cell death) is vital for development and observed in tumors post-treatment.
  • The role of apoptosis in tumor response to therapy remains an area of investigation.

Purpose of the Study:

  • To investigate the correlation between tumor cell apoptosis and response to radiation therapy.
  • To explore the heterogeneity of apoptosis propensity in tumors and its genetic underpinnings.

Main Methods:

  • Studies utilizing murine tumor models.
  • Assessment of tumor cell apoptosis and correlation with radiation response.

Main Results:

  • Tumor cell apoptosis propensity correlates with radiation response in murine models.

Related Experiment Videos

  • Pretreatment apoptotic index showed the strongest correlation with radiocurability.
  • Significant heterogeneity in apoptosis propensity was observed within and among different tumor types.
  • Conclusions:

    • Apoptosis may govern tumor radiocurability by regulating clonogen number.
    • Apoptosis is under complex genetic control, involving oncogenes and tumor suppressor genes.
    • Understanding apoptosis pathways could lead to therapeutic strategies for modulating treatment response.